JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB273687

Recombinant Human ACE2 protein (Fc Chimera)

Be the first to review this product! Submit a review

|

(6 Publications)

Recombinant Human ACE2 protein (Fc Chimera) is a Human Fragment protein, in the 18 to 615 aa range, expressed in HEK 293 cells, with >95%, < 1 EU/mg endotoxin level, suitable for SDS-PAGE, ELISA, HPLC.

View Alternative Names

UNQ868/PRO1885, ACE2, Angiotensin-converting enzyme 2, Angiotensin-converting enzyme homolog, Angiotensin-converting enzyme-related carboxypeptidase, Metalloprotease MPROT15, ACEH, ACE-related carboxypeptidase

4 Images
ELISA - Recombinant Human ACE2 protein (Fc Chimera) (AB273687)
  • ELISA

Supplier Data

ELISA - Recombinant Human ACE2 protein (Fc Chimera) (AB273687)

ab273687 binding to immobilized SARS-CoV-2 RBD Fc fusion protein. 96-well plate was coated with the SARS-CoV-2 RBD Fc fusion protein at 5 μg/ml. ab273687 was titrated on a 3-fold serial dilution starting at 10 μg/ml.

ELISA - Recombinant Human ACE2 protein (Fc Chimera) (AB273687)
  • ELISA

Supplier Data

ELISA - Recombinant Human ACE2 protein (Fc Chimera) (AB273687)

RBD Fc binding to immobilized ACE2 Fc fusion proteins. 96-well plates were coated with ab273687 and Recombinant Human ACE2 (mutated H374 N + H378 N) protein (Fc Chimera) (ab273885) at 5 μg/ml. The SARS-CoV-2 RBD Fc fusion protein conjugated to HRP was titrated on a 3-fold serial dilution starting at 10 μg/ml.

HPLC - Recombinant Human ACE2 protein (Fc Chimera) (AB273687)
  • HPLC

Supplier Data

HPLC - Recombinant Human ACE2 protein (Fc Chimera) (AB273687)

HPLC analysis of ab273687.

SDS-PAGE - Recombinant Human ACE2 protein (Fc Chimera) (AB273687)
  • SDS-PAGE

Supplier Data

SDS-PAGE - Recombinant Human ACE2 protein (Fc Chimera) (AB273687)

SDS-PAGE analysis of 2.5 μg ab273687.

Lane 1 : Non-reduced.

Lane 2 : Reduced.

Key facts

Purity

>95%

Endotoxin level

< 1 EU/mg

Expression system

HEK 293 cells

Tags

Fc tag C-Terminus

Applications

ELISA, SDS-PAGE, HPLC

applications

Biologically active

No

Accession

Q9BYF1

Animal free

No

Carrier free

No

Species

Human

Storage buffer

Constituents: PBS

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "HPLC": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Sequence info

[{"sequence":"QSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNITEENVQNMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQALQQNGSSVLSEDKSKRLNTILNTMSTIYSTGKVCNPDNPQECLLLEPGLNEIMANSLDYNERLWAWESWRSEVGKQLRPLYEEYVVLKNEMARANHYEDYGDYWRGDYEVNGVDGYDYSRGQLIEDVEHTFEEIKPLYEHLHAYVRAKLMNAYPSYISPIGCLPAHLLGDMWGRFWTNLYSLTVPFGQKPNIDVTDAMVDQAWDAQRIFKEAEKFFVSVGLPNMTQGFWENSMLTDPGNVQKAVCHPTAWDLGKGDFRILMCTKVTMDDFLTAHHEMGHIQYDMAYAAQPFLLRNGANEGFHEAVGEIMSLSAATPKHLKSIGLLSPDFQEDNETEINFLLKQALTIVGTLPFTYMLEKWRWMVFKGEIPKDQWMKKWWEMKREIVGVVEPVPHDETYCDPASLFHVSNDYSFIRYYTRTLYQFQFQEALCQAAKHEGPLHKCDISNSTEAGQKLFNMLRLGKSEPWTLALENVVGAKNMNVRPLLNYFEPLFTWLKDQNKNSFVGWSTDWSPYADGGGGSGGGGSDKTHTCPPCPAPEAAGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","proteinLength":"Fragment","predictedMolecularWeight":"190.06 kDa","actualMolecularWeight":null,"aminoAcidEnd":615,"aminoAcidStart":18,"nature":"Recombinant","expressionSystem":"HEK 293 cells","accessionNumber":"Q9BYF1","tags":[{"tag":"Fc","terminus":"C-Terminus"}]}]

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
False

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The ACE2 protein also known as angiotensin-converting enzyme 2 is an essential component in the renin-angiotensin system. It functions mechanically by converting the hormone angiotensin II to angiotensin-(1-7) which helps regulate blood pressure and fluid balance. The molecular weight of ACE2 is approximately 120 kDa. This protein is expressed in various tissues particularly the lungs heart kidneys and gastrointestinal tract. In cultured cells like Caco-2 cells researchers often study this expression.
Biological function summary

The ACE2 protein plays an important role in the regulation of cardiovascular and renal functions. It is a single-pass type I membrane protein and its activity reduces inflammation and oxidative stress in cells. ACE2 does not function as part of a larger protein complex but its enzymatic conversion has a substantial impact on reducing the effects of angiotensin II in the body leading to vasodilation and decreased blood pressure.

Pathways

ACE2 involvement is significant in the renin-angiotensin system and the kallikrein-kinin system. These pathways are essential for maintaining cardiovascular homeostasis. In the renin-angiotensin system ACE2 works in opposition to angiotensin-converting enzyme (ACE) balancing the effects through the production of angiotensin-(1-7) from angiotensin II. Additionally ACE2 interacts indirectly with proteins like angiotensin receptor type 1 (AT1) and angiotensin receptor type 2 (AT2) ensuring proper signaling and physiological responses.

ACE2 links closely with conditions such as hypertension and COVID-19. Increased activity of angiotensin II due to low ACE2 levels contributes to hypertension. In infectious disease SARS-CoV-2 virus responsible for COVID-19 uses ACE2 as an entry receptor to initiate infection in host cells. This interaction highlights the importance of ACE2 in disease pathogenesis and has prompted interest in ACE2 as a potential therapeutic target.

Specifications

Form

Liquid

General info

Function

Essential counter-regulatory carboxypeptidase of the renin-angiotensin hormone system that is a critical regulator of blood volume, systemic vascular resistance, and thus cardiovascular homeostasis (PubMed : 27217402). Converts angiotensin I to angiotensin 1-9, a nine-amino acid peptide with anti-hypertrophic effects in cardiomyocytes, and angiotensin II to angiotensin 1-7, which then acts as a beneficial vasodilator and anti-proliferation agent, counterbalancing the actions of the vasoconstrictor angiotensin II (PubMed : 10924499, PubMed : 10969042, PubMed : 11815627, PubMed : 14504186, PubMed : 19021774). Also removes the C-terminal residue from three other vasoactive peptides, neurotensin, kinetensin, and des-Arg bradykinin, but is not active on bradykinin (PubMed : 10969042, PubMed : 11815627). Also cleaves other biological peptides, such as apelins (apelin-13, [Pyr1]apelin-13, apelin-17, apelin-36), casomorphins (beta-casomorphin-7, neocasomorphin) and dynorphin A with high efficiency (PubMed : 11815627, PubMed : 27217402, PubMed : 28293165). In addition, ACE2 C-terminus is homologous to collectrin and is responsible for the trafficking of the neutral amino acid transporter SL6A19 to the plasma membrane of gut epithelial cells via direct interaction, regulating its expression on the cell surface and its catalytic activity (PubMed : 18424768, PubMed : 19185582).. (Microbial infection) Acts as a receptor for human coronaviruses SARS-CoV and SARS-CoV-2, as well as human coronavirus NL63/HCoV-NL63.. Isoform 2. Non-functional as a carboxypeptidase.. Isoform 2. (Microbial infection) Non-functional as a receptor for human coronavirus SARS-CoV-2.

Sequence similarities

Belongs to the peptidase M2 family.

Post-translational modifications

N-glycosylation on Asn-90 may limit SARS infectivity.. Proteolytic cleavage by ADAM17 generates a secreted form (PubMed:15983030, PubMed:33713620). Also cleaved by serine proteases: TMPRSS2, TMPRSS11D and HPN/TMPRSS1.. Phosphorylated. Phosphorylation at Tyr-781 probably inhibits interaction with AP2M1 and enables interactions with proteins containing SH2 domains.. Ubiquitinated. Ubiquitinated on Lys-788 via 'Lys-48'-linked ubiquitin (PubMed:36876523). 'Lys-48'-linked deubiquitinated by USP50 on the Lys-788; leading to its stabilization (PubMed:36876523).

Product protocols

Target data

Essential counter-regulatory carboxypeptidase of the renin-angiotensin hormone system that is a critical regulator of blood volume, systemic vascular resistance, and thus cardiovascular homeostasis (PubMed : 27217402). Converts angiotensin I to angiotensin 1-9, a nine-amino acid peptide with anti-hypertrophic effects in cardiomyocytes, and angiotensin II to angiotensin 1-7, which then acts as a beneficial vasodilator and anti-proliferation agent, counterbalancing the actions of the vasoconstrictor angiotensin II (PubMed : 10924499, PubMed : 10969042, PubMed : 11815627, PubMed : 14504186, PubMed : 19021774). Also removes the C-terminal residue from three other vasoactive peptides, neurotensin, kinetensin, and des-Arg bradykinin, but is not active on bradykinin (PubMed : 10969042, PubMed : 11815627). Also cleaves other biological peptides, such as apelins (apelin-13, [Pyr1]apelin-13, apelin-17, apelin-36), casomorphins (beta-casomorphin-7, neocasomorphin) and dynorphin A with high efficiency (PubMed : 11815627, PubMed : 27217402, PubMed : 28293165). In addition, ACE2 C-terminus is homologous to collectrin and is responsible for the trafficking of the neutral amino acid transporter SL6A19 to the plasma membrane of gut epithelial cells via direct interaction, regulating its expression on the cell surface and its catalytic activity (PubMed : 18424768, PubMed : 19185582).. (Microbial infection) Acts as a receptor for human coronaviruses SARS-CoV and SARS-CoV-2, as well as human coronavirus NL63/HCoV-NL63.. Isoform 2. Non-functional as a carboxypeptidase.. Isoform 2. (Microbial infection) Non-functional as a receptor for human coronavirus SARS-CoV-2.
See full target information ACE2

Publications (6)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in immunology 13:906687 PubMed35784352

2022

Glucocorticoids Bind to SARS-CoV-2 S1 at Multiple Sites Causing Cooperative Inhibition of SARS-CoV-2 S1 Interaction With ACE2.

Applications

Unspecified application

Species

Unspecified reactive species

Hassan Sarker,Rashmi Panigrahi,Eugenio Hardy,J N Mark Glover,Shokrollah Elahi,Carlos Fernandez-Patron

Small (Weinheim an der Bergstrasse, Germany) 18:e2200836 PubMed35607768

2022

SARS-CoV-2 Spike Stem Protein Nanoparticles Elicited Broad ADCC and Robust Neutralization against Variants in Mice.

Applications

Unspecified application

Species

Unspecified reactive species

Yao Ma,Ye Wang,Chunhong Dong,Gilbert X Gonzalez,Wandi Zhu,Joo Kim,Lai Wei,Sang-Moo Kang,Bao-Zhong Wang

Scientific reports 11:20383 PubMed34650130

2021

Immunodominant linear B cell epitopes in the spike and membrane proteins of SARS-CoV-2 identified by immunoinformatics prediction and immunoassay.

Applications

Unspecified application

Species

Unspecified reactive species

Kanokporn Polyiam,Waranyoo Phoolcharoen,Namphueng Butkhot,Chanya Srisaowakarn,Arunee Thitithanyanont,Prasert Auewarakul,Tawatchai Hoonsuwan,Marasri Ruengjitchatchawalya,Phenjun Mekvichitsaeng,Yaowaluck Maprang Roshorm

Cell reports. Medicine 1:100142 PubMed33163980

2020

Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Alexander Carpinteiro,Michael J Edwards,Markus Hoffmann,Georg Kochs,Barbara Gripp,Sebastian Weigang,Constantin Adams,Elisa Carpinteiro,Anne Gulbins,Simone Keitsch,Carolin Sehl,Matthias Soddemann,Barbara Wilker,Markus Kamler,Thomas Bertsch,Karl S Lang,Sameer Patel,Gregory C Wilson,Silke Walter,Hartmut Hengel,Stefan Pöhlmann,Philipp A Lang,Johannes Kornhuber,Katrin Anne Becker,Syed A Ahmad,Klaus Fassbender,Erich Gulbins

Scientific reports 10:17698 PubMed33077899

2020

Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana.

Applications

Unspecified application

Species

Unspecified reactive species

Kaewta Rattanapisit,Balamurugan Shanmugaraj,Suwimon Manopwisedjaroen,Priyo Budi Purwono,Konlavat Siriwattananon,Narach Khorattanakulchai,Oranicha Hanittinan,Wanuttha Boonyayothin,Arunee Thitithanyanont,Duncan R Smith,Waranyoo Phoolcharoen

The Journal of biological chemistry : PubMed32917722

2020

Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2.

Applications

Unspecified application

Species

Unspecified reactive species

Michael J Edwards,Katrin Anne Becker,Barbara Gripp,Markus Hoffmann,Simone Keitsch,Barbara Wilker,Matthias Soddemann,Anne Gulbins,Elisa Carpinteiro,Sameer H Patel,Gregory C Wilson,Stefan Pöhlmann,Silke Walter,Klaus Fassbender,Syed A Ahmad,Alexander Carpinteiro,Erich Gulbins
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com